EC Number | Application | Comment | Organism |
---|---|---|---|
2.7.11.18 | medicine | therapeutic inhibition via specific chemical inhibitors of endothelial isozyme, i.e. 11-(3-chloro-6-immino-6H-pyridazin-1-yl)-undecanoic acid (6-phenyl-pyridazin-3-yl)-amide, represents an important new target for the treatment of inflammatory lung disease with less side effects than other therapies | Mus musculus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.11.18 | additional information | construction of eMLCK or smMLCK knockout mutant mice by genetic or chemical methods, overview | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.11.18 | 11-(3-chloro-6-iminopyridazin-1(6H)-yl)-N-(6-phenylpyridazin-3-yl)undecanamide | highly specific inhibitor, competitive to ATP binding | Mus musculus | |
2.7.11.18 | KT5926 | i.e. (8R,9S,11S)-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9,10-tetrahydro-8,11-epoxy,1H,8H,11H-2,7beta,11alpha-triazadeibenzo[a,g]cycloocta[cde]triden-1-one, specific inhibitor | Homo sapiens | |
2.7.11.18 | ML-7 | i.e. 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine HCl, specific inhibitor | Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.7.11.18 | 108000 | - |
smooth muscle isozyme | Mus musculus |
2.7.11.18 | 130000 | 150000 | smooth muscle isozyme | Homo sapiens |
2.7.11.18 | 210000 | - |
endothelial isozyme | Mus musculus |
2.7.11.18 | 214000 | - |
endothelial isozyme | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.11.18 | ATP + [myosin light chain] | Mus musculus | - |
ADP + [myosin light chain] phosphate | - |
? | |
2.7.11.18 | ATP + [myosin light chain] | Homo sapiens | activation of the enzyme is a key regulatory step in the modulation of endothelial permeability, central to parthogenesis of inflammatory lung disease is disruption of the endothelial barrier function | ADP + [myosin light chain] phosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.11.18 | Homo sapiens | - |
2 isozymes encoded by a single gene and translated from 2 different splicing variants | - |
2.7.11.18 | Mus musculus | - |
2 isozymes encoded by a single gene and translated from 2 different splicing variants | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.11.18 | endothelium | specific isozyme | Mus musculus | - |
2.7.11.18 | endothelium | specific isozyme | Homo sapiens | - |
2.7.11.18 | smooth muscle | specific isozyme | Mus musculus | - |
2.7.11.18 | smooth muscle | specific isozyme | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.11.18 | ATP + [myosin light chain] | - |
Mus musculus | ADP + [myosin light chain] phosphate | - |
? | |
2.7.11.18 | ATP + [myosin light chain] | - |
Homo sapiens | ADP + [myosin light chain] phosphate | - |
? | |
2.7.11.18 | ATP + [myosin light chain] | activation of the enzyme is a key regulatory step in the modulation of endothelial permeability, central to parthogenesis of inflammatory lung disease is disruption of the endothelial barrier function | Homo sapiens | ADP + [myosin light chain] phosphate | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.7.11.18 | More | the endothelial isozyme possesses a catalytic domain including the actin-binding domain and the calmodulin binding domain, like the smooth muscle isozyme, but also a protein-protein interaction domain including SH2 and SH3 domains | Mus musculus |
2.7.11.18 | More | the endothelial isozyme possesses a catalytic domain including the actin-binding domain and the calmodulin binding domain, like the smooth muscle isozyme, but also a protein-protein interaction domain including SH2 and SH3 domains | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.11.18 | endothelial MLCK | - |
Mus musculus |
2.7.11.18 | endothelial MLCK | - |
Homo sapiens |
2.7.11.18 | endothelial myosin light chain kinase | - |
Mus musculus |
2.7.11.18 | endothelial myosin light chain kinase | - |
Homo sapiens |
2.7.11.18 | MLCK | - |
Mus musculus |
2.7.11.18 | MLCK | - |
Homo sapiens |
2.7.11.18 | myosine light chain kinase | - |
Mus musculus |
2.7.11.18 | myosine light chain kinase | - |
Homo sapiens |
2.7.11.18 | smMLCK | - |
Mus musculus |
2.7.11.18 | smMLCK | - |
Homo sapiens |
2.7.11.18 | smooth muscle myosin light chain kinase | - |
Mus musculus |
2.7.11.18 | smooth muscle myosin light chain kinase | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.11.18 | ATP | - |
Mus musculus | |
2.7.11.18 | ATP | - |
Homo sapiens |